The global GI stool testing market is anticipated to grow at a considerable CAGR of 7.1% during the forecast. Gastrointestinal infections (GI) are caused by a variety of viruses, bacteria, and parasites. The gastrointestinal pathogen panel simultaneously tests for the presence of multiple disease-causing (pathogenic) microbes in a stool sample. The GI pathogen panel detects the genetic material (RNA or DNA) of some of the more common pathogens. It can identify co-infections (more than one microbe causing the infection) and identify microbes that might be missed with traditional testing. The rising prevalence of diarrhea across the globe is expected to raise the demand for the GI stool testing market during the forecast period. For instance, according to the World Health Organization, diarrheal disease is the second leading cause of death in children under five years old. Globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. Moreover, each year diarrhea kills around 5,25,000 children under five.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/gi-stool-testing-market
The technological advancements by market players across the globe are expected to hold a prominent share of the market during the forecast period. For instance, in January 2022, Exact Sciences Corp. announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing overall sensitivity of 95.2% for colorectal cancer (CRC) at the specificity of 92.4% for negative samples confirmed by colonoscopy. Furthermore, Cologuard is the first and only FDA-approved, non-invasive stool DNA test used to screen average-risk people for CRC. Exact Sciences is developing a second-generation Cologuard to improve the specificity and precancer sensitivity of the test, decreasing the false positive rate and increasing the detection rate of precancerous lesions.
Global GI Stool Testing Market Report Segment
By Product Type
- Instruments
- Reagents)
By Test Type
- Microscopy
- Occult Blood Test
- Ova and Parasites Test
- Bacteria Test
- Fecal Biomarkers Test
- Other Test Types
By End-Users
- Hospitals
- Home
- Diagnostic Centers & Laboratories
- Academic Institutions and Research Centers
A full report of GI Stool Testing Market is available at: https://www.omrglobal.com/industry-reports/gi-stool-testing-market
GI Stool Testing Market– Segment by Region
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories
- Alere, Inc.
- Beckman Coulter Inc.
- bioMerieux SA
- Biometrix Labs
- Bio-Rad Laboratories
- Cardinal Health, Inc.
- Cenogenics Corp.
- CTK Biotech Inc.
- Danaher Corp.
- DiaSorin S.p.A
- Diagnostic Solutions Laboratory, LLC
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/